Skip to main content

New technologies for National Health Screening examined

25 June 2014

This is the third oral evidence session for the Committee’s inquiry into National Health Screening.

This session will focus on how new technologies and scientific advances hold the potential to alter the way screening is delivered. This includes changing exactly who is invited to participate as well as the conditions and diseases they are screened for.

The first panel comprises members of the academic community and cancer charities who are involved with, or are funding research into, novel approaches to screening. The current governance arrangements for implementing, modifying and withdrawing screening programmes will be addressed by the second panel which features officials from Public Health England, Public Health Wales and the UK National Screening Committee.


Wednesday 25 June, Thatcher Room, Portcullis House

At 9.15 am

  • Owen Sharp, Chief Executive, Prostate Cancer UK
  • Professor Ian Cree, Yvonne Carter Professor of Pathology, Warwick Medical School, representing the Early Cancer Detection Consortium
  • Dr Hilary Burton, Director, PHG Foundation
  • Professor Ian Jacobs, Principal investigator, PROMISE 2016

At 10.15 am

  • Dr Anne Mackie, Director of Programmes, UK National Screening Committee
  • Dr Kevin Dunbar, Director, National Chlamydia Screening Programme
  • Jamie Waterall, National Lead - NHS Health Check programme, Public Health England
  • Dr Sharon Hillier, Deputy Director Screening Division, Public Health Wales

Further information